Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion

Published:2020-12-01 Issue:3 Volume:40 Page:197-216
ISSN:0883-0185
Container-title:International Reviews of Immunology
language:en
Short-container-title:International Reviews of Immunology

Author:

Arianfar Elaheh¹,Shahgordi Sanaz¹,Memarian Ali²³

Affiliation:

1. Student Research Committee, Faculty of Medicine, Department of Immunology, Golestan University of Medical Sciences, Gorgan, Iran;

2. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran;

3. Immunology department, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

Funder

Iran National Science Foundation

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08830185.2020.1845670

Reference252 articles.

1. Cancer statistics, 2020

2. Theranostic and Molecular Classification of Breast Cancer

3. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment

4. Cancer immunoediting: from immunosurveillance to tumor escape

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review concerning the breast cancer-related tumour microenvironment;Critical Reviews in Oncology/Hematology;2024-07

2. Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look;Cell Communication and Signaling;2024-02-15

3. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer;International Journal of Biological Sciences;2024

4. Identification of UBFD1 as a prognostic biomarker and molecular target among estrogen receptor-positive breast cancer;Biochemical and Biophysical Research Communications;2023-12

5. Advances in immunotherapy for triple-negative breast cancer;Molecular Cancer;2023-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3